← USPTO Patent Applications

ONCOLYTIC VIRUS EXPRESSING AN IMMUNE CELL ENGAGER FOR TUMOR TARGETING

Application US20260077006A1 Kind: A1 Mar 19, 2026

Inventors

Xiaohu Liu, I-Fang Lee, Yanal M. Murad

Abstract

An HSV vector with an expression cassette encoding an immune cell engager protein under control of an EF1α promoter. ICP27 under control of a CEA promoter. ICP34.5 under control of miRNA-124/143, and ICP47 under control of a ICP27 promoter is disclosed. The HSV vector also includes deletion of one copy of terminal repeat long region and one copy of terminal repeat short region. The immune cell engager protein comprises a T-cell binding domain and a tumor-associated antigen binding domain.

CPC Classifications

A61K 35/763 A61P 35/00 C07K 14/005 C07K 16/2803 C07K 16/2809 C07K 16/2818 C07K 16/2827 C07K 16/2875 C07K 16/2878 C07K 16/3092 C12N 7/00 C12N 15/1133 C07K 2317/31 C07K 2317/569 C07K 2317/622 C12N 2310/141 C12N 2710/16621 C12N 2710/16622 C12N 2710/16632

Filing Date

2023-09-08

Application No.

19110072